Perbedaan CSIS WARRANT SERIES I dan Merck Tbk.: CSIS WARRANT SERIES I diperdagangkan di Rp88 (kapitalisasi pasar 4,34 M, volume 24 jam 16,1 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 387,1× kapitalisasi pasar CSIS WARRANT SERIES I, dan Merck Tbk. lebih aktif diperdagangkan (33,3 rb vs 16,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CSIS-W | MERK | |
|---|---|---|
Kapitalisasi Pasar | 4,34 M | 1,68 T |
Volume | 16,1 rb | 33,3 rb |
Lot | 161 | 333 |
Perputaran | 1,31 jt | 126,46 jt |
Harga Rata-rata | 81,55 | 3.797,72 |
Nilai Transaksi | 1,31 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 88 | 3.800 |
Volume Ekuilibrium Indikatif | 1 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Selengkapnya di halaman CSIS-W →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →